A bone marrow biopsy checks whether lymphoma has reached the marrow — a key part of staging. This guide explains why the test is ordered, what a bone marrow test in lymphoma involves, and what marrow involvement means for your treatment.
A bone marrow biopsy is a test that samples the soft, spongy tissue inside your bones where blood cells are made. In lymphoma, its main purpose is to answer one question: has the lymphoma spread into the bone marrow? This is called marrow involvement, and knowing the answer is an important part of working out the stage of your lymphoma and choosing the right treatment.
The test is usually done after lymphoma has already been diagnosed on a lymph node biopsy. The node biopsy tells your team what kind of lymphoma you have; the bone marrow test — often described as a bone marrow test for lymphoma — helps show how far it has reached. It is one piece of a bigger staging picture that also includes scans, blood tests and your LDH level.
Not everyone with lymphoma needs a bone marrow biopsy. For many Hodgkin lymphomas, and increasingly for some other subtypes, a modern PET-CT scan can show marrow involvement without a needle test. Your specialist decides based on your subtype and guidelines. For the full picture, see the Lymphoma hub and our Lymphoma Treatment in Hyderabad page.
A bone marrow biopsy is no longer routine for every lymphoma. For classical Hodgkin lymphoma, current guidance is that a PET-CT scan is sensitive enough to detect marrow involvement, so a routine bone marrow biopsy can often be omitted. It is still commonly recommended for several non-Hodgkin lymphomas, where marrow involvement changes the stage and the plan. (Source: ESMO Clinical Practice Guidelines and NCCN Guidelines for Hodgkin and non-Hodgkin lymphomas.)
The test is not about making the diagnosis — that is usually already done. It is about mapping the disease accurately so treatment is neither too little nor too much.
Finding lymphoma cells in the marrow, or confirming they are absent, helps place your lymphoma into a stage from I to IV. Accurate staging is what lets your team choose the right intensity and type of treatment for your situation.
Marrow involvement in lymphoma means cancer cells have infiltrated the bone marrow. Because lymphoma often spreads in patches, a solid core biopsy is the most reliable way to catch it. Its presence generally points towards whole-body (systemic) treatment.
If your blood tests show low red cells, white cells or platelets, a marrow sample can show whether lymphoma in the marrow is the cause — important information before starting treatment.
The sample can be sent for flow cytometry, immunohistochemistry and molecular testing — adding detail about the subtype that can refine both the plan and the outlook.
Diagnosing and staging lymphoma is a sequence of tests, each answering a different question. Here is where the bone marrow biopsy sits.
Lymphoma is diagnosed and subtyped on a lymph node. An excisional biopsy of the whole node is preferred over a fine-needle aspirate, and a core needle biopsy is an alternative when surgery is not practical.
A PET-CT scan shows where lymphoma is active throughout the body — and, for many subtypes, can now reveal marrow involvement without a needle test.
When imaging is unclear, or the subtype calls for it, the bone marrow biopsy gives a definitive answer on marrow involvement and provides tissue for detailed testing.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Been advised a bone marrow biopsy, want to understand what marrow involvement means, or need a second opinion on your staging before treatment? CION's lymphoma team is here.
Understanding the steps ahead of time takes a lot of the worry out of the procedure. It is a short, outpatient test — you go home the same day. Two samples are usually taken together in one sitting.
Your team reviews your medicines — especially any blood thinners — and checks your platelet count. You lie on your side or your front, and the skin over the back of the hip bone (the posterior iliac crest) is cleaned. A local anaesthetic is injected to numb the skin and the surface of the bone.
A thin needle is passed to the marrow and a small amount of liquid marrow is drawn out — the bone marrow aspiration. You may feel a brief pulling or aching sensation for a few seconds. This liquid is ideal for looking at individual cells and for flow cytometry and genetic tests. (This is the same step people mean when they refer to a bone marrow aspiration as a separate test.)
A slightly wider needle then removes a small solid core of bone and marrow — the trephine biopsy. This is the part that lets the pathologist see the marrow structure intact and judge whether lymphoma has infiltrated it. For a lymphoma marrow test, this core is the most important sample.
The site is covered with a small dressing. The whole process takes around 15–30 minutes. Mild soreness for a day or two is normal; you can usually return to gentle activity soon after, avoiding heavy lifting for about a day.
Preliminary microscope findings may be back within a few days, but the complete report often takes one to two weeks, because several tests are run on the sample. The pathologist looks at the core under the microscope and applies these tools:
The report will state whether the marrow is involved or not involved, and if involved, roughly how extensively. These findings feed into your overall pathology picture and are combined with your scans and blood work at a multidisciplinary tumour board before your treatment plan is finalised.
A stage IV label in lymphoma is not the alarm signal it is with many solid tumours. Even when the marrow is involved, outcomes can be very good: with modern chemo-immunotherapy, published series report roughly 80–90% long-term survival for Hodgkin lymphoma and around 60–70% for diffuse large B-cell lymphoma, the commonest aggressive non-Hodgkin type. Figures vary widely by subtype, stage and individual factors. (Source: figures reported in published lymphoma outcome series, consistent with NCCN and ESMO guidance.)
If lymphoma is found in the marrow, it usually means the disease is stage IV — it has reached an area beyond the lymph nodes. It is natural to find that word frightening, but with lymphoma the picture is more hopeful than it sounds: many lymphomas with marrow involvement remain highly treatable, and some are curable.
What marrow involvement mainly changes is the type of treatment. Because the disease is no longer confined to one area, treatment is usually systemic — whole-body therapy that reaches cancer cells wherever they are — rather than radiation to a single site. Depending on your subtype, this may combine chemotherapy with an anti-CD20 monoclonal antibody and other classes of drug. We describe therapy here by mechanism only; the specific regimens are chosen for your case and explained on the Lymphoma Treatment in Hyderabad page.
CION delivers chemotherapy, antibody-based immunotherapy, targeted therapy, radiation (IMRT) and supportive care directly. Where an intensive approach such as a stem-cell transplant is appropriate, it is coordinated through accredited partner facilities. Every case is reviewed by a tumour board, and you can ask our lymphoma doctors to walk you through exactly what your results mean.
Staging decisions carry real weight, and a second opinion can be genuinely valuable in a few situations:
CION offers a dedicated, free written second-opinion service at our Hyderabad lymphoma centre. You deserve a plan built around healing, not billing — with transparent costs explained up front. Request your free second opinion or call 18002028726.
Get a free written second opinion from CION's lymphoma team — especially useful if a bone marrow biopsy has been advised or your marrow report is unclear.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.A bone marrow biopsy checks whether lymphoma cells have spread into the marrow — the spongy tissue inside your bones where blood cells are made. This is called marrow involvement, and finding it (or ruling it out) helps confirm the stage of your lymphoma and shape the treatment plan. The test is usually done after the diagnosis is made on a lymph node biopsy, as part of staging. Not everyone needs one anymore — for many Hodgkin lymphomas and some others, a PET-CT scan can now show marrow involvement without a biopsy. Your specialist decides based on your lymphoma subtype and NCCN/ESMO guidance. Discuss your case on our Lymphoma Treatment page.
They are two parts of the same procedure, usually done together in one sitting. A bone marrow aspiration draws out a small amount of the liquid marrow through a needle — good for looking at individual cells and for tests like flow cytometry and genetic studies. A bone marrow biopsy (also called a trephine biopsy) removes a small solid core of bone and marrow, which lets the pathologist see the marrow architecture intact and judge how much, if any, lymphoma is present. For a lymphoma bone marrow test, the core biopsy is the more important of the two for detecting marrow involvement, because lymphoma often infiltrates the marrow in patches.
A bone marrow biopsy is done under local anaesthetic, which numbs the skin and the surface of the bone. You will usually feel a brief, deep pressure or a short pulling ache when the marrow is drawn and when the core is taken — this lasts only seconds. Most people describe it as uncomfortable rather than severely painful, and it is over in around 15–30 minutes. Mild soreness at the site for a day or two afterwards is normal and settles with simple pain relief. If you are anxious, tell your team — light sedation can sometimes be arranged. You can go home the same day and resume normal activity soon after, avoiding heavy lifting for a day.
In adults, the sample is almost always taken from the back of the hip bone — the posterior iliac crest, the bony ridge you can feel at the top of your buttock on either side of the spine. This spot is chosen because the bone sits just under the skin, holds a rich, representative amount of marrow, and is well away from major organs and large blood vessels, which makes the procedure safe. You lie on your side or your front for it. The breastbone (sternum) is occasionally used for aspiration only in adults, but for a lymphoma marrow test the hip is standard because it allows both the aspirate and the solid core biopsy to be taken together.
If lymphoma cells are found in the marrow, it usually means the lymphoma is stage IV — that it has reached an area beyond the lymph nodes. That sounds alarming, but with lymphoma, stage IV is not the same as it is with many solid tumours: many lymphomas with marrow involvement are still very treatable, and some are highly curable. What marrow involvement mainly changes is that treatment is systemic (whole-body) — typically chemo-immunotherapy that reaches cancer cells everywhere — rather than radiation to one area alone. It is one input among several, alongside your subtype, LDH level and PET findings. Your team explains what it means for you on the Lymphoma Treatment page.
Preliminary results are often available within a few days, but the complete report — the part that matters most for lymphoma — can take one to two weeks, because several specialised tests are run on the sample. A pathologist examines the core under the microscope and applies immunohistochemistry to detect and characterise any lymphoma cells. Flow cytometry reads the surface markers on the cells, and molecular and genetic testing may look for specific abnormalities. Together these confirm whether the marrow is involved and, if so, by which lymphoma subtype. The findings are then combined with your scans and blood work at a tumour board before your plan is finalised.
A bone marrow biopsy is a very safe, routine procedure with a low complication rate. The most common after-effect is mild bruising, soreness or a small amount of bleeding at the site, which settles on its own within a few days. Serious complications — significant bleeding or infection — are rare. Your team will ask about blood-thinning medicines and any bleeding tendency beforehand, and will check your platelet count, taking precautions if needed. The procedure is performed under sterile conditions by an experienced clinician. If you develop increasing pain, spreading redness, fever, or fresh bleeding afterwards, contact your team. For most patients the information the test provides far outweighs its small risks.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.